RemeOs is the first and only bioresorbable metal implant approved by the FDA, with successful clinical trials conducted in the ankle, according to a March 30 press release.
Bioretec plans to launch the screw in the U.S. in collaboration with hospitals and professionals specializing in ankle fractures.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
